View in EDS

The mammalian target of rapamycin contributes to synovial fibroblast pathogenicity in rheumatoid arthritis.

Saved in:
Bibliographic Details
Title: The mammalian target of rapamycin contributes to synovial fibroblast pathogenicity in rheumatoid arthritis.
Authors: Barker BE; Molecular Rheumatology, School of Medicine, Trinity College Dublin, Trinity Biomedical Sciences Institute, Dublin, Ireland.; Translational Immunopathology, School of Biochemistry & Immunology and School of Medicine, Trinity College Dublin, Trinity Biomedical Sciences Institute, Dublin, Ireland., Hanlon MM; Molecular Rheumatology, School of Medicine, Trinity College Dublin, Trinity Biomedical Sciences Institute, Dublin, Ireland.; EULAR Centre of Excellence, Centre for Arthritis and Rheumatic Diseases, St. Vincent's University Hospital, Dublin, Ireland., Marzaioli V; Molecular Rheumatology, School of Medicine, Trinity College Dublin, Trinity Biomedical Sciences Institute, Dublin, Ireland.; EULAR Centre of Excellence, Centre for Arthritis and Rheumatic Diseases, St. Vincent's University Hospital, Dublin, Ireland., Smith CM; School of Biochemistry and Immunology, Trinity College Dublin, Trinity Biomedical Sciences Institute, Dublin, Ireland., Cunningham CC; Molecular Rheumatology, School of Medicine, Trinity College Dublin, Trinity Biomedical Sciences Institute, Dublin, Ireland.; EULAR Centre of Excellence, Centre for Arthritis and Rheumatic Diseases, St. Vincent's University Hospital, Dublin, Ireland., Fletcher JM; School of Biochemistry and Immunology, Trinity College Dublin, Trinity Biomedical Sciences Institute, Dublin, Ireland.; School of Medicine, Trinity College Dublin, Trinity Biomedical Sciences Institute, Dublin, Ireland., Veale DJ; EULAR Centre of Excellence, Centre for Arthritis and Rheumatic Diseases, St. Vincent's University Hospital, Dublin, Ireland., Fearon U; Molecular Rheumatology, School of Medicine, Trinity College Dublin, Trinity Biomedical Sciences Institute, Dublin, Ireland.; EULAR Centre of Excellence, Centre for Arthritis and Rheumatic Diseases, St. Vincent's University Hospital, Dublin, Ireland., Canavan M; Translational Immunopathology, School of Biochemistry & Immunology and School of Medicine, Trinity College Dublin, Trinity Biomedical Sciences Institute, Dublin, Ireland.
Source: Frontiers in medicine [Front Med (Lausanne)] 2023 Feb 03; Vol. 10, pp. 1029021. Date of Electronic Publication: 2023 Feb 03 (Print Publication: 2023).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101648047 Publication Model: eCollection Cited Medium: Print ISSN: 2296-858X (Print) Linking ISSN: 2296858X NLM ISO Abbreviation: Front Med (Lausanne) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36817783
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The mammalian target of rapamycin contributes to synovial fibroblast pathogenicity in rheumatoid arthritis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Barker+BE%22">Barker BE</searchLink>; Molecular Rheumatology, School of Medicine, Trinity College Dublin, Trinity Biomedical Sciences Institute, Dublin, Ireland.; Translational Immunopathology, School of Biochemistry & Immunology and School of Medicine, Trinity College Dublin, Trinity Biomedical Sciences Institute, Dublin, Ireland.<br /><searchLink fieldCode="AU" term="%22Hanlon+MM%22">Hanlon MM</searchLink>; Molecular Rheumatology, School of Medicine, Trinity College Dublin, Trinity Biomedical Sciences Institute, Dublin, Ireland.; EULAR Centre of Excellence, Centre for Arthritis and Rheumatic Diseases, St. Vincent's University Hospital, Dublin, Ireland.<br /><searchLink fieldCode="AU" term="%22Marzaioli+V%22">Marzaioli V</searchLink>; Molecular Rheumatology, School of Medicine, Trinity College Dublin, Trinity Biomedical Sciences Institute, Dublin, Ireland.; EULAR Centre of Excellence, Centre for Arthritis and Rheumatic Diseases, St. Vincent's University Hospital, Dublin, Ireland.<br /><searchLink fieldCode="AU" term="%22Smith+CM%22">Smith CM</searchLink>; School of Biochemistry and Immunology, Trinity College Dublin, Trinity Biomedical Sciences Institute, Dublin, Ireland.<br /><searchLink fieldCode="AU" term="%22Cunningham+CC%22">Cunningham CC</searchLink>; Molecular Rheumatology, School of Medicine, Trinity College Dublin, Trinity Biomedical Sciences Institute, Dublin, Ireland.; EULAR Centre of Excellence, Centre for Arthritis and Rheumatic Diseases, St. Vincent's University Hospital, Dublin, Ireland.<br /><searchLink fieldCode="AU" term="%22Fletcher+JM%22">Fletcher JM</searchLink>; School of Biochemistry and Immunology, Trinity College Dublin, Trinity Biomedical Sciences Institute, Dublin, Ireland.; School of Medicine, Trinity College Dublin, Trinity Biomedical Sciences Institute, Dublin, Ireland.<br /><searchLink fieldCode="AU" term="%22Veale+DJ%22">Veale DJ</searchLink>; EULAR Centre of Excellence, Centre for Arthritis and Rheumatic Diseases, St. Vincent's University Hospital, Dublin, Ireland.<br /><searchLink fieldCode="AU" term="%22Fearon+U%22">Fearon U</searchLink>; Molecular Rheumatology, School of Medicine, Trinity College Dublin, Trinity Biomedical Sciences Institute, Dublin, Ireland.; EULAR Centre of Excellence, Centre for Arthritis and Rheumatic Diseases, St. Vincent's University Hospital, Dublin, Ireland.<br /><searchLink fieldCode="AU" term="%22Canavan+M%22">Canavan M</searchLink>; Translational Immunopathology, School of Biochemistry & Immunology and School of Medicine, Trinity College Dublin, Trinity Biomedical Sciences Institute, Dublin, Ireland.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101648047%22">Frontiers in medicine</searchLink> [Front Med (Lausanne)] 2023 Feb 03; Vol. 10, pp. 1029021. <i>Date of Electronic Publication: </i>2023 Feb 03 (<i>Print Publication: </i>2023).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media+S%2EA%22">Frontiers Media S.A </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101648047 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2296-858X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222296858X%22">2296858X </searchLink><i>NLM ISO Abbreviation: </i>Front Med (Lausanne) <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36817783
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fmed.2023.1029021
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1029021
    Titles:
      – TitleFull: The mammalian target of rapamycin contributes to synovial fibroblast pathogenicity in rheumatoid arthritis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Barker BE
      – PersonEntity:
          Name:
            NameFull: Hanlon MM
      – PersonEntity:
          Name:
            NameFull: Marzaioli V
      – PersonEntity:
          Name:
            NameFull: Smith CM
      – PersonEntity:
          Name:
            NameFull: Cunningham CC
      – PersonEntity:
          Name:
            NameFull: Fletcher JM
      – PersonEntity:
          Name:
            NameFull: Veale DJ
      – PersonEntity:
          Name:
            NameFull: Fearon U
      – PersonEntity:
          Name:
            NameFull: Canavan M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 03
              M: 02
              Text: 2023 Feb 03
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-print
              Value: 2296-858X
          Numbering:
            – Type: volume
              Value: 10
          Titles:
            – TitleFull: Frontiers in medicine
              Type: main
ResultId 1